Axon Enterprise, Inc $AXON Stock Position Decreased by Evolutionary Tree Capital Management LLC

Evolutionary Tree Capital Management LLC lessened its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 27.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,890 shares of the biotechnology company’s stock after selling 1,811 shares during the period. Axon Enterprise makes up about 3.9% of Evolutionary Tree Capital Management LLC’s investment portfolio, making the stock its 10th largest holding. Evolutionary Tree Capital Management LLC’s holdings in Axon Enterprise were worth $2,077,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in AXON. Creative Financial Designs Inc. ADV purchased a new stake in shares of Axon Enterprise in the fourth quarter worth $28,000. Sound Income Strategies LLC increased its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares in the last quarter. Camelot Portfolios LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at $30,000. AlphaCentric Advisors LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth about $34,000. Finally, Lodestone Wealth Management LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth about $35,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the sale, the insider directly owned 34,024 shares in the company, valued at $16,501,640. The trade was a 4.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the transaction, the president directly owned 169,125 shares of the company’s stock, valued at $82,609,106.25. The trade was a 7.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 58,989 shares of company stock worth $30,527,983. 4.20% of the stock is owned by company insiders.

Axon Enterprise Trading Up 0.5%

Shares of NASDAQ:AXON opened at $527.76 on Friday. The company has a market cap of $42.54 billion, a P/E ratio of 211.95, a PEG ratio of 10.72 and a beta of 1.38. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $885.91. The stock’s fifty day moving average price is $497.09 and its 200-day moving average price is $476.61.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.90 million. During the same period last year, the firm posted $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. Sell-side analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of analyst reports. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a report on Thursday, June 25th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Finally, Morgan Stanley set a $600.00 price target on shares of Axon Enterprise in a report on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $725.25.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.